Topics

University of Chicago scientists rewired Bifidobacterium longum to pump SumIL-2 inside tumors, suppressing pancreatic cancer growth in mouse models.

AI-driven drug discovery is transforming biotechnology as Big Tech acquires biotech startups, redefining pharmaceutical innovation and the future of AI-powered healthcare.

EPFL researchers activate three genes in memory neurons to reverse age-related decline and improve recall in models of Alzheimer's disease, offering new hope for brain health.

Researchers create a protein fiber that records cell activities over time, helping scientists study large groups of cells and uncover details about brain functions and diseases.

Breakthrough uses directed evolution to develop versatile tool for medicine and research, overcoming natural limits of DNA-copying enzymes.

A Boston startup gains FDA approval to begin the first clinical trial using cellular reprogramming to treat eye disease, with potential implications for reversing aspects of aging.

MIT's DIAL system offers precise, adjustable control over protein expression in synthetic gene circuits to enhance uniform cell reprogramming and enable tailored therapies.

KAIST researchers create a method to find and restore key genes in disrupted cellular networks, offering potential for cancer treatments, drug development, and personalized medicine through precise control.